Bagratuni T - Search Results

1

Receptor-Binding-Domain-Specific B Cell Responses Induced by mRNA Immunization against SARS-CoV-2.

Geropeppa M, Papadatou I, Sarantis P, Tzanoudaki M, Ntanasis-Stathopoulos I, Bagratuni T, Terpos E, Spoulou V. Geropeppa M, et al. Among authors: bagratuni t. Vaccines (Basel). 2023 Jun 25;11(7):1148. doi: 10.3390/vaccines11071148. Vaccines (Basel). 2023. PMID: 37514964 Free PMC article.

2

Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens.

Bagratuni T, Kastritis E, Politou M, Roussou M, Kostouros E, Gavriatopoulou M, Eleutherakis-Papaiakovou E, Kanelias N, Terpos E, Dimopoulos MA. Bagratuni T, et al. Am J Hematol. 2013 Sep;88(9):765-70. doi: 10.1002/ajh.23504. Epub 2013 Jul 24. Am J Hematol. 2013. PMID: 23757261 Free article.

3

Decreased incidence of EPCR 4678G/C SNP in multiple myeloma patients with thrombosis.

Dri AP, Politou M, Gialeraki A, Bagratuni T, Kanellias N, Terpos E. Dri AP, et al. Among authors: bagratuni t. Thromb Res. 2013 Sep;132(3):400-1. doi: 10.1016/j.thromres.2013.07.024. Epub 2013 Aug 8. Thromb Res. 2013. PMID: 23993723 No abstract available.

4

TLR4/TIRAP polymorphisms are associated with progression and survival of patients with symptomatic myeloma.

Bagratuni T, Terpos E, Eleutherakis-Papaiakovou E, Kalapanida D, Gavriatopoulou M, Migkou M, Liacos CI, Tasidou A, Matsouka C, Mparmparousi D, Dimopoulos MA, Kastritis E. Bagratuni T, et al. Br J Haematol. 2016 Jan;172(1):44-7. doi: 10.1111/bjh.13786. Epub 2015 Nov 13. Br J Haematol. 2016. PMID: 26564000 Free article.

5

Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy.

Kastritis E, Melea P, Bagratuni T, Melakopoulos I, Gavriatopoulou M, Roussou M, Migkou M, Eleutherakis-Papaiakovou E, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: bagratuni t. Leuk Lymphoma. 2017 Oct;58(10):2304-2309. doi: 10.1080/10428194.2017.1300889. Epub 2017 Jun 11. Leuk Lymphoma. 2017. PMID: 28604257

6

Milder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events.

Tsakiri EN, Terpos E, Papanagnou ED, Kastritis E, Brieudes V, Halabalaki M, Bagratuni T, Florea BI, Overkleeft HS, Scorrano L, Skaltsounis AL, Dimopoulos MA, Trougakos IP. Tsakiri EN, et al. Among authors: bagratuni t. Sci Rep. 2017 Dec 19;7(1):17802. doi: 10.1038/s41598-017-17596-4. Sci Rep. 2017. PMID: 29259189 Free PMC article.

7

Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myeloma.

Terpos E, Ntanasis-Stathopoulos I, Christoulas D, Bagratuni T, Bakogeorgos M, Gavriatopoulou M, Eleutherakis-Papaiakovou E, Kanellias N, Kastritis E, Dimopoulos MA. Terpos E, et al. Among authors: bagratuni t. Blood Cancer J. 2018 May 11;8(5):42. doi: 10.1038/s41408-018-0075-6. Blood Cancer J. 2018. PMID: 29748532 Free PMC article.

8

Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies.

Bagratuni T, Ntanasis-Stathopoulos I, Gavriatopoulou M, Mavrianou-Koutsoukou N, Liacos C, Patseas D, Kanellias N, Migkou M, Ziogas DC, Eleutherakis-Papaiakovou E, Roussou M, Fotiou D, Terpos E, Kastritis E, Dimopoulos MA. Bagratuni T, et al. Leukemia. 2018 Dec;32(12):2617-2625. doi: 10.1038/s41375-018-0197-7. Epub 2018 Jul 19. Leukemia. 2018. PMID: 30026568 Free PMC article.

9

Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis.

Kastritis E, Gavriatopoulou M, Roussou M, Bagratuni T, Migkou M, Fotiou D, Ziogas DC, Kanellias N, Eleutherakis-Papaiakovou E, Dialoupi I, Ntanasis-Stathopoulos I, Spyropoulou-Vlachou M, Psimenou E, Gakiopoulou H, Marinaki S, Papadopoulou E, Ntalianis A, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: bagratuni t. Amyloid. 2018 Dec;25(4):234-241. doi: 10.1080/13506129.2018.1540410. Epub 2019 Jan 20. Amyloid. 2018. PMID: 30663408

10

Toll-Like Receptor 4 Activation Promotes Multiple Myeloma Cell Growth and Survival Via Suppression of The Endoplasmic Reticulum Stress Factor Chop.

Bagratuni T, Sklirou AD, Kastritis E, Liacos CI, Spilioti C, Eleutherakis-Papaiakovou E, Kanellias N, Gavriatopoulou M, Terpos E, Trougakos IP, Dimopoulos MA. Bagratuni T, et al. Sci Rep. 2019 Mar 1;9(1):3245. doi: 10.1038/s41598-019-39672-7. Sci Rep. 2019. PMID: 30824741 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page